StocksFin Logo
PTCT logo
$PTCT

PTC Therapeutics, Inc.

PTCT country of incorporation
|
https://www.ptcbio.com
|
Dr. Stuart Peltz
|
1,167 employees
NASDAQ | Healthcare | Biotechnology
PTCT reported its Q322 earnings on October 27, 2022 (99 weeks ago).
$217.13M 56.5% vs. Q321 Revenues Q322
93.55% -1.8% vs. Q321 Gross Profit Margin
-50.35% ! 47.7% vs. Q321 Net Profit Margin
-64.07M ! 16.8% vs. Q321 Free Cash Flow Q322
$-1.53 ! 19% vs. Q321 EPS Q322
Company Card Q322
As reported on October 27, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on October 27, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
217.13M
+31.2%
14.01M
-109.32M
+28.1%
$-1.53
Q22022
165.53M
+11.3%
9.64M
-152.09M
-20%
$-2.13
Q12022
148.74M
10.14M
-126.73M
$-1.78
FY2021
538.59M
 32.33M
-523.9M
$-7.26
Q42021
165.23M
+19.1%
9.33M
-143.27M
-7.2%
$-2.03
Q32021
138.74M
+18.9%
6.54M
-133.62M
-12.9%
$-1.89
Q22021
116.68M
-1.1%
7.36M
-118.37M
+8%
$-1.68
Q12021
117.94M
9.1M
-128.64M
$-1.83
FY2020
380.77M
 18.94M
-438.16M
$-6.64
FY2019
306.98M
 12.14M
-251.58M
$-4.27
FY2018
264.73M
 12.67M
-128.08M
$-2.75
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
1.58B
 1.8B
104.42M
415.03M
-226.9M
Q22022
1.8B
 1.99B
158.16M
599.47M
-182.22M
Q12022
1.8B
 1.89B
144.18M
532.15M
-90.58M
FY2021
1.94B
 1.94B
189.72M
695.19M
1.44M
FY2020
2.21B
 1.73B
208.81M
429.18M
481.98M
FY2019
1.62B
 1.03B
288.03M
333.86M
594.33M
FY2018
1.12B
 768.5M
169.5M
164.68M
350.73M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-38.05M
 136.45M
-140M
-26.03M
-64.07M
+12.5%
Q22022
-55.24M
 72.25M
3.86M
-17.99M
-73.23M
+59.1%
Q12022
-97.4M
 49.04M
1.17M
-81.45M
-178.85M
FY2021
-251.33M
 219.18M
20.88M
-85.33M
-336.66M
FY2020
-194.07M
 -561.55M
668.72M
-55.98M
-250.05M
FY2019
-98.64M
 -387.24M
613.21M
-45.44M
-144.08M
FY2018
-27.64M
 -42.61M
131.57M
-15.53M
-43.17M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees